Results 181 to 190 of about 55,948 (258)

Characterisation and prognostic implications of the 12-lead electrocardiogram in children with RASopathy-associated hypertrophic cardiomyopathy. [PDF]

Heart
Boleti O, Sunjaya A, Field E, Norrish G, Tollit J, Cervi E, Kaski JP.   +6 more
europepmc   +1 more source

Genomic Architecture and Cascade Screening Gaps in Hypertrophic Cardiomyopathy: A Real-World Analysis. [PDF]

J Clin Med
Kato K, Ishikawa A, Mariya T, Kouzu H, Yano T, Kawaharata W, Takasu Y, Miura A, Seto A, Suda K, Sakurai A.   +10 more
europepmc   +1 more source

Fatal Infantile Cardiomyopathy Associated with a Homozygous <i>MYL2</i> c.413T>A (p.Met138Lys) Variant: A Case Expanding the Recessive <i>MYL2</i> Phenotypic Spectrum. [PDF]

Genes (Basel)
Uddin MS, Alnamshan Y, Shafeen K, Jahan SN, AlMadhi N, Gurumurthy K, Hassan AB, Esmail A, AlQannas M.   +8 more
europepmc   +1 more source

Supranormal Ejection Fraction as a Clinical Red Flag: Differentiating Hemodynamic Stress From Intrinsic Cardiomyopathy in Heart Failure. [PDF]

Mayo Clin Proc Innov Qual Outcomes
Chen Y, Su X, Jiang J, Tang J, Qiu Z, Yang W, Jin W.   +6 more
europepmc   +1 more source

What Do We Know About Hypertrophic Cardiomyopathy in Poland in the Period 2016-2021 Based on Data From the Public Health System? [PDF]

Int J Public Health
Niemiec M, Stec M, Grzybowski J, Cegłowska U, Wiśniewska A, Hałgas K, Czepczor K, Podolski M, Gruchlik B, Orzeł-Łomozik G, Cieśla D, Gąsior M, Hryniewiecki T, Leszek P, Caforio ALP, Mizia-Stec K.   +15 more
europepmc   +1 more source